Ameriprise Financial Inc. Buys 4,146 Shares of Amedisys, Inc. (NASDAQ:AMED)

Ameriprise Financial Inc. lifted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 12.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 38,009 shares of the health services provider's stock after acquiring an additional 4,146 shares during the period. Ameriprise Financial Inc. owned approximately 0.12% of Amedisys worth $3,451,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. AQR Arbitrage LLC increased its position in shares of Amedisys by 59.1% during the fourth quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock worth $42,812,000 after acquiring an additional 175,311 shares in the last quarter. Schonfeld Strategic Advisors LLC grew its stake in shares of Amedisys by 17.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 4,500 shares of the health services provider's stock worth $409,000 after acquiring an additional 671 shares in the last quarter. Pentwater Capital Management LP grew its stake in shares of Amedisys by 178.3% in the 4th quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock worth $107,132,000 after acquiring an additional 756,000 shares in the last quarter. Northern Trust Corp grew its stake in shares of Amedisys by 23.6% in the 4th quarter. Northern Trust Corp now owns 289,228 shares of the health services provider's stock worth $26,259,000 after acquiring an additional 55,264 shares in the last quarter. Finally, Vazirani Asset Management LLC purchased a new position in shares of Amedisys in the 4th quarter worth about $908,000. 94.36% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AMED. Stephens reissued an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Finally, Wall Street Zen downgraded shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $100.75.

Amedisys Stock Performance

Amedisys stock traded up $0.45 during midday trading on Friday, reaching $94.39. The stock had a trading volume of 220,524 shares, compared to its average volume of 410,899. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The firm's 50-day moving average price is $93.48 and its 200 day moving average price is $91.59. The firm has a market capitalization of $3.10 billion, a PE ratio of 37.46, a P/E/G ratio of 1.78 and a beta of 0.96. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same period in the prior year, the business posted $1.03 earnings per share. The company's revenue was up 4.1% on a year-over-year basis. As a group, research analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.